Vanguard Group’s Pulmatrix PULM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$105K Sell
47,082
-2,327
-5% -$10.1K ﹤0.01% 4170
2025
Q3
$241K Buy
49,409
+2,400
+5% +$12.7K ﹤0.01% 4097
2025
Q2
$325K Buy
47,009
+4,607
+11% +$31.7K ﹤0.01% 4009
2025
Q1
$282K Buy
42,402
+7,320
+21% +$53.8K ﹤0.01% 4001
2024
Q4
$245K Hold
35,082
﹤0.01% 4069
2024
Q3
$75.1K Hold
35,082
﹤0.01% 4220
2024
Q2
$67.7K Hold
35,082
﹤0.01% 4267
2024
Q1
$61.4K Hold
35,082
﹤0.01% 4291
2023
Q4
$65.3K Buy
35,082
+13,548
+63% +$25.9K ﹤0.01% 4348
2023
Q3
$43.7K Buy
21,534
+144
+0.7% +$355 ﹤0.01% 4423
2023
Q2
$57.3K Sell
21,390
-20,294
-49% -$57.1K ﹤0.01% 4445
2023
Q1
$122K Sell
41,684
-5,587
-12% -$20.2K ﹤0.01% 4383
2022
Q4
$183K Buy
47,271
+58
+0.1% +$210 ﹤0.01% 4323
2022
Q3
$169K Sell
47,213
-35,244
-43% -$157K ﹤0.01% 4439
2022
Q2
$378K Buy
82,457
+1
+0% +$5 ﹤0.01% 4355
2022
Q1
$563K Sell
82,456
-19,487
-19% -$141K ﹤0.01% 4374
2021
Q4
$892K Sell
101,943
-436
-0.4% -$5.96K ﹤0.01% 4292
2021
Q3
$1.64M Hold
102,379
﹤0.01% 4119
2021
Q2
$2.13M Buy
102,379
+15,164
+17% +$307K ﹤0.01% 3954
2021
Q1
$2.32M Buy
87,215
+8,338
+11% +$255K ﹤0.01% 3830
2020
Q4
$1.88M Sell
78,877
-1,244
-2% -$29.6K ﹤0.01% 3677
2020
Q3
$1.91M Buy
80,121
+1,681
+2% +$42.8K ﹤0.01% 3501
2020
Q2
$2.7M Buy
78,440
+70,565
+896% +$2.24M ﹤0.01% 3346
2020
Q1
$159K Buy
7,875
+2,595
+49% +$75.7K ﹤0.01% 3892
2019
Q4
$91K Hold
5,280
﹤0.01% 4015
2019
Q3
$86K Buy
5,280
+898
+20% +$15.7K ﹤0.01% 4046
2019
Q2
$81K Buy
4,382
+913
+26% +$19.9K ﹤0.01% 4068
2019
Q1
$88K Buy
3,469
+496
+17% +$16.6K ﹤0.01% 4022
2018
Q4
$143K Sell
2,973
-102
-3% -$7.52K ﹤0.01% 3945
2018
Q3
$228K Sell
3,075
-187
-6% -$15.9K ﹤0.01% 3985
2018
Q2
$294K Buy
3,262
+1,313
+67% +$128K ﹤0.01% 3924
2018
Q1
$198K Buy
1,949
+807
+71% +$232K ﹤0.01% 3954
2017
Q4
$323K Buy
1,142
+575
+101% +$195K ﹤0.01% 3843
2017
Q3
$232K Buy
567
+68
+14% +$27.7K ﹤0.01% 3887
2017
Q2
$240K Buy
499
+37
+8% +$20K ﹤0.01% 3872
2017
Q1
$323K Buy
462
+390
+542% +$232K ﹤0.01% 3827
2016
Q4
$8K Sell
72
-65
-47% -$12.8K ﹤0.01% 4074
2016
Q3
$45K Buy
137
+36
+36% +$13.5K ﹤0.01% 4039
2016
Q2
$40K Hold
101
﹤0.01% 4092
2016
Q1
$58K Hold
101
﹤0.01% 4066
2015
Q4
$79K Buy
+101
New +$91.3K ﹤0.01% 4101

Other funds holding PULM

Vanguard Group's PULM Position: Q4 2025 in Review

Vanguard Group reduced its Pulmatrix (PULM) stake by 4.7% in Q4 2025, selling an estimated $10.1K and leaving 47,082 shares worth $105K. The position accounts for ﹤0.01% of the portfolio, ranked #4170.

Vanguard Group first reported a position in PULM in Q4 2015 and has held it in 41 quarters since. The position peaked at $2.7M in Q2 2020. 15 funds tracked by Wall St. Rank hold PULM as of Q4 2025.

  • Vanguard Group held 47,082 shares of Pulmatrix worth $105K as of Q4 2025.
  • Vanguard Group sold 2,327 Pulmatrix shares in Q4 2025, an estimated $10.1K.
  • Pulmatrix made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #4170 holding.
  • Vanguard Group first reported a position in Pulmatrix in Q4 2015 and has held it in 41 quarters since.
  • Vanguard Group's Pulmatrix position peaked at $2.7M in Q2 2020.
  • 15 funds tracked by Wall St. Rank held Pulmatrix as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.